Validated HPLC/MS/MS assay for CI-1011 in rat plasma and a comparison with an HPLC/UV assay

Journal of Pharmaceutical and Biomedical Analysis

Volumn 17, Issue 8, 1998, Pages 1399-1413

  Bullen, William W ^a   Lathia, Chetan D ^a   Abel, Robert B ^a   Hayes, Roger N ^a  

^a PFIZER INC   (United States)

Author keywords

Antiathersclerotic agent; CI 1011; LC MS MS; Lipid regulator

Indexed keywords

ANTILIPEMIC AGENT; SULFAMIC ACID ((2,4,6 TRIS (1 METHYLETHYL) PHENYL)ACETYL) 2,6 BIS(1 METHYLETHYL) PHENYL ESTER; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALIBRATION; CONTROLLED STUDY; DRUG STABILITY; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY CONTROL; RAT; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

ACETATES; ADMINISTRATION, ORAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; MALE; MASS SPECTROMETRY; RATS; REPRODUCIBILITY OF RESULTS; SULFONIC ACIDS;

EID: 0032582250     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(98)00034-X     Document Type: Article

References (5)

1. Lee H.T., Sliskovic D.R., Picard J.A., Roth B.D., Wierenga W., Hicks J.L., Bousley R.F., Hamelehle K.L., Homan R., Speyer C., Stanfield R.L., Krause B.R. J. Med. Chem. 39:1996;5031-5034.
2. T.M.A. Bocan, W. Rosebury, S. Bakmueller, P. Lee, S. Kuchera, H. Lee, XII Int. Symp. Drugs Affecting Lipid Metabolism. Baylor College of Medicine, Houston, TX, 1995, p. 132.
3. P.R. Bevington, Data Reduction and Error Analysis for the Physical Sciences. McGraw-Hill, New York, 1969, p. 105.
4. Lin L.I. Biometrics. 45:1989;255-268.
5. Lathia C., Krause B., Bullen W., Stanfield R., Bousley R., Milad M. Pharm. Res. 14:1997;S362.